General Anesthesia — MCQs

Q: Diffusion hypoxia is seen with which drug?

Nitrous oxide. **Explanation:** **Nitrous Oxide (N₂O)** is the correct answer because of its unique pharmacokinetic property: high solubility in blood compared to nitrogen, but low overall solubility compared to other anesthetics. **The Mechanism (Fink Effect):** Diffusion hypoxia occurs during the **recovery phase** of anesthesia. When N₂O administration is stopped, it rushes out of the blood and into the alveoli down its concentration gradient. Because N₂O is 30 times more soluble than nitrogen, it floods the alveoli in massive volumes. This "dilutes" the alveolar oxygen and carbon dioxide. The resulting drop in alveolar oxygen tension ($PAO_2$) leads to arterial hypoxemia. To prevent this, clinicians administer **100% oxygen for 5–10 minutes** after discontinuing N₂O. **Analysis of Incorrect Options:** * **Ketamine:** An intravenous NMDA receptor antagonist. It does not involve alveolar gas exchange mechanisms and is known for maintaining airway reflexes and respiratory drive. * **Theophylline:** A methylxanthine used as a bronchodilator in asthma/COPD. It is not an anesthetic gas and does not cause diffusion hypoxia. * **Halothane:** A volatile inhalational anesthetic. While it can cause respiratory depression, it does not diffuse in large enough volumes to dilute alveolar oxygen significantly. **High-Yield NEET-PG Pearls:** * **Second Gas Effect:** N₂O speeds up the induction of a companion volatile anesthetic (e.g., Halothane) by creating a "vacuum" in the alveoli as it is rapidly absorbed. * **Concentration Effect:** The higher the concentration of N₂O inhaled, the more rapidly the arterial concentration rises. * **Contraindication:** N₂O should be avoided in closed-space pathologies (e.g., pneumothorax, intestinal obstruction, middle ear surgery) because it expands air-filled cavities.

Q: Thiopentone is used for induction anesthesia because it is:

Smooth induction. **Explanation:** **Thiopentone sodium**, an ultra-short-acting barbiturate, has been the "gold standard" induction agent for decades. The primary reason it is favored for induction is its ability to provide a **smooth and rapid induction** (Option A). Upon intravenous administration, it crosses the blood-brain barrier within seconds (one arm-brain circulation time), leading to a predictable and pleasant loss of consciousness without significant excitatory phenomena. **Analysis of Options:** * **Rapidly redistributed (Options B & C):** While it is true that the *recovery* from a single bolus dose of Thiopentone occurs due to rapid redistribution from the brain to lean tissues (muscle and fat), this is the mechanism for **emergence**, not the reason it is chosen for **induction**. Furthermore, "Rapid redistribution" is a pharmacokinetic property, whereas "Smooth induction" describes the clinical goal of the induction phase. * **Easy to monitor (Option D):** Thiopentone does not have specific bedside monitoring advantages over other agents like Propofol or Etomidate. In fact, its long elimination half-life makes it harder to manage during prolonged infusions compared to newer agents. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Potentiates GABA-A receptors, increasing the **duration** of chloride channel opening. * **Context-Sensitive Half-life:** It has a very long elimination half-life; repeated doses lead to "hangover" effects due to saturation of fat stores. * **Neuroprotection:** It is a potent cerebral vasoconstrictor, decreasing Cerebral Blood Flow (CBF) and Intracranial Pressure (ICP), making it ideal for neurosurgery. * **Contraindication:** Absolutely contraindicated in **Porphyria** (induces ALA synthetase). * **Complication:** Accidental intra-arterial injection causes severe vasospasm and gangrene (Treatment: Intra-arterial Heparin, Papaverine, or Lidocaine).

Q: Which stage of surgical anesthesia is characterized by the transition from regular respiration to the cessation of breathing?

Regular respiration to cessation of breathing. This question refers to **Guedel’s Classification**, which describes the four stages of anesthesia based on clinical signs observed during the administration of ether. ### **Explanation of the Correct Answer** The question describes **Stage III (Surgical Anesthesia)**. This stage is divided into four planes. It begins with the onset of **regular rhythmic respiration** (Plane 1) and progresses until there is a **complete cessation of spontaneous breathing** (end of Plane 4), leading into Stage IV (Medullary Paralysis). In modern practice, this is the stage where most surgical procedures are performed, characterized by the loss of spinal reflexes and skeletal muscle relaxation. ### **Analysis of Incorrect Options** * **Option A (Loss of Consciousness):** This marks the end of **Stage I (Analgesia)** and the beginning of Stage II. It does not define the transition to respiratory cessation. * **Option B (Failure of Circulation):** This occurs in **Stage IV (Medullary Paralysis/Overdose)**. Stage IV begins with the cessation of respiration and ends with circulatory collapse and death if the anesthetic is not withdrawn. * **Option D (Loss of Consciousness to regular respiration):** This defines **Stage II (Delirium/Excitement)**. It is characterized by irregular breathing, struggling, and breath-holding. It ends when regular respiration is re-established. ### **High-Yield Clinical Pearls for NEET-PG** * **Guedel’s Stages** were originally described for **Ether**; they are less distinct with modern rapid-acting intravenous agents (like Propofol). * **Stage II (Excitement)** is the most dangerous stage due to the risk of laryngospasm, vomiting, and cardiac arrhythmias. * **Plane 2 of Stage III** is generally considered the ideal plane for most surgeries. * **Key Sign of Stage IV:** Dilated, non-reactive pupils and vasomotor collapse.

Q: Which of the following is a short-acting non-depolarizing muscle relaxant?

Rocuronium. **Explanation:** Muscle relaxants are classified based on their mechanism of action (Depolarizing vs. Non-depolarizing) and their duration of action (Short, Intermediate, or Long-acting). **Why Rocuronium is the correct answer:** Among the non-depolarizing neuromuscular blocking agents (NMBAs), **Rocuronium** is clinically categorized as having a rapid onset and an intermediate duration of action. However, in the context of competitive exams like NEET-PG, it is often grouped as the "shortest-acting" among the commonly used non-depolarizing agents when compared to long-acting drugs like Pancuronium. More importantly, it is the drug of choice for **Rapid Sequence Induction (RSI)** when Succinylcholine is contraindicated, due to its fast onset (60–90 seconds). **Analysis of Incorrect Options:** * **A. Succinylcholine:** This is a **depolarizing** muscle relaxant. While it is ultra-short-acting, the question specifically asks for a *non-depolarizing* agent. * **C. Atracurium:** This is an **intermediate-acting** non-depolarizing agent. It is unique for its metabolism via **Hofmann elimination**, making it safe in liver and kidney failure. * **D. Pancuronium:** This is a **long-acting** steroid-based non-depolarizing agent. It is known for causing vagolytic effects (tachycardia). **High-Yield Clinical Pearls for NEET-PG:** * **Mivacurium** is technically the shortest-acting non-depolarizing NMBA (metabolized by plasma cholinesterase), but it is often absent from options; in such cases, Rocuronium or intermediate agents are evaluated. * **Sugammadex** is the specific reversal agent for Rocuronium and Vecuronium. * **Hoffman Elimination:** A pH and temperature-dependent non-enzymatic degradation (seen with Atracurium and Cisatracurium). * **Drug of choice in Renal Failure:** Cisatracurium.

Q: All of the following are modes to decrease pain on injection caused by propofol except?

Use vein on the dorsum of hand. **Explanation:** Propofol is a highly lipophilic drug, but its aqueous phase contains free propofol molecules that irritate the venous intima and activate the **kallikrein-kinin system**, leading to significant pain on injection. **Why Option C is the Correct Answer (The "Except"):** Using a vein on the **dorsum of the hand** actually **increases** the incidence and severity of pain compared to larger, more proximal veins. For NEET-PG, remember that the gold standard for reducing propofol-induced pain is using a **large-bore cannula in a large vein** (e.g., the antecubital fossa), which allows for faster dilution of the drug and less contact with the vessel wall. **Analysis of Other Options:** * **A. Mix Lignocaine with Propofol:** This is the most common clinical practice. Lignocaine (10–40 mg) acts as a local anesthetic on the vein wall and stabilizes the kinin cascade. * **B. Give Fentanyl prior to Propofol:** Pre-treatment with opioids like Fentanyl or Alfentanil increases the pain threshold and provides central analgesia, effectively reducing the injection pain. * **D. Cooling of the Drug:** Cooling propofol to 4°C reduces the concentration of free propofol in the aqueous phase and slows down the activation of pain mediators. **High-Yield Clinical Pearls for NEET-PG:** * **Propofol Formulation:** It is an emulsion (1% propofol, 10% soybean oil, 2.25% glycerol, and 1.2% egg phosphatide). * **Other methods to reduce pain:** Using Long-Chain Triglyceride/Medium-Chain Triglyceride (LCT/MCT) emulsions or the **Bier’s Block technique** (applying a tourniquet before injecting lignocaine). * **Contraindication:** Avoid propofol in patients with a documented severe allergy to **egg yolk** (though most egg allergies are to the albumin in the white).

Q: Which of the following inhalational agents has the maximum blood gas solubility coefficient?

Isoflurane. **Explanation:** The **Blood-Gas Solubility Coefficient (λ)** represents the affinity of an inhalational anesthetic for blood compared to alveolar gas. It is the primary determinant of the **speed of induction and recovery**: the higher the solubility, the slower the induction. **1. Why Isoflurane is Correct:** Among the options provided, **Isoflurane** has the highest blood-gas partition coefficient (**1.4**). Because it is more soluble in blood, it acts as a "reservoir," requiring more molecules to dissolve in the blood before the partial pressure in the alveoli and brain can equilibrate. This results in a **slower induction and emergence** compared to the other agents listed. **2. Analysis of Incorrect Options:** * **Sevoflurane (0.65):** It has intermediate solubility. It is the agent of choice for mask induction in pediatrics due to its pleasant odor and non-irritant nature. * **Nitrous Oxide (0.47):** Despite being very insoluble, its induction is rapid due to the "Concentration Effect" and "Second Gas Effect." * **Desflurane (0.42):** It has the **lowest** blood-gas solubility among the options. This allows for the fastest titration and the most rapid recovery, making it ideal for morbidly obese patients. **High-Yield Clinical Pearls for NEET-PG:** * **Solubility vs. Speed:** Solubility is **inversely proportional** to the speed of induction (High solubility = Slow induction). * **Potency:** Determined by **MAC (Minimum Alveolar Concentration)**. Potency is inversely proportional to MAC. * **Order of Solubility (Highest to Lowest):** Halothane (2.4) > Isoflurane (1.4) > Sevoflurane (0.65) > Nitrous Oxide (0.47) > Desflurane (0.42). * **Oil-Gas Partition Coefficient:** Correlates with **potency** (Meyer-Overton Hypothesis). Halothane has the highest oil-gas solubility, making it the most potent.

Q: Who coined the term "balanced anesthesia"?

Lundy. **Explanation:** The correct answer is **Lundy (C)**. **John Silas Lundy** coined the term **"Balanced Anesthesia"** in 1926. The concept refers to the use of a combination of different anesthetic agents and techniques (such as hypnotics, analgesics, and muscle relaxants) to achieve the desired components of anesthesia—unconsciousness, analgesia, and muscle relaxation. This approach allows for smaller doses of each individual drug, thereby minimizing their specific side effects and increasing the safety margin for the patient. **Analysis of Incorrect Options:** * **A. Simpson:** Sir James Young Simpson is famous for discovering the anesthetic properties of **Chloroform** and introducing its use in obstetrics. * **B. Fischer:** Emil Fischer was a chemist who synthesized **Barbital** (the first barbiturate), but he did not coin the term balanced anesthesia. * **D. Moan:** This is a distractor and is not associated with any major milestone in the history of anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Father of Anesthesia:** William T.G. Morton (first successful public demonstration of Ether in 1846). * **First use of Ether:** Crawford Long (1842), though he did not publish his results immediately. * **Term "Anesthesia":** Coined by Oliver Wendell Holmes. * **Triad of Anesthesia:** Traditionally includes **Hypnosis, Analgesia, and Muscle Relaxation**. Modern practice often adds "Areflexia" or "Autonomic Stability." * **Lundy's Contribution:** Apart from balanced anesthesia, he is also credited with the clinical introduction of **Thiopental sodium** in 1934.

Q: Which is a depolarizing skeletal muscle relaxant?

Suxamethonium. ### Explanation **Correct Answer: A. Suxamethonium** **Mechanism of Action:** Suxamethonium (Succinylcholine) is the **only** depolarizing neuromuscular blocking agent (NMBA) used clinically. It acts as an agonist at the nicotinic acetylcholine receptors (nAChR) at the motor endplate. Unlike acetylcholine, it is not metabolized by acetylcholinesterase, leading to prolonged depolarization. This results in initial muscle twitching (**fasciculations**) followed by flaccid paralysis because the post-junctional membrane becomes unresponsive to subsequent stimuli (Phase I block). **Analysis of Incorrect Options:** Options B, C, and D are all **Non-depolarizing NMBAs**. They act as competitive antagonists at the nAChR, preventing acetylcholine from binding. * **B. Mivacurium:** A short-acting benzylisoquinolone metabolized by plasma cholinesterase. * **C. Pancuronium:** A long-acting aminosteroid known for causing tachycardia (vagolytic effect). * **D. Vecuronium:** An intermediate-acting aminosteroid with minimal cardiovascular side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Suxamethonium is rapidly hydrolyzed by **Pseudocholinesterase** (Plasma cholinesterase). A deficiency in this enzyme leads to prolonged apnea. * **Onset/Duration:** It has the fastest onset (30–60 seconds) and shortest duration (5–10 minutes), making it the drug of choice for **Rapid Sequence Induction (RSI)**. * **Key Side Effects:** Hyperkalemia (avoid in burns, trauma, and denervation injuries), muscle soreness, increased intraocular/intragastric pressure, and it is a potent trigger for **Malignant Hyperthermia**. * **Antidote:** There is no pharmacological reversal for a Phase I block; however, Sugammadex can reverse aminosteroids like Vecuronium and Rocuronium.

Q: Which of the following statements about nitrous oxide is FALSE?

It is a good muscle relaxant.. **Explanation:** Nitrous oxide ($N_2O$) is a commonly used inhalational anesthetic agent, but it possesses specific pharmacological properties that make Option D the false statement. **Why Option D is Correct (The False Statement):** Nitrous oxide is a potent analgesic but a very weak anesthetic (MAC = 104%). Crucially, it has **no muscle relaxant properties**. In clinical practice, it must be supplemented with neuromuscular blocking agents or more potent volatile anesthetics (like Isoflurane) to achieve the surgical relaxation required for abdominal or thoracic procedures. **Analysis of Other Options:** * **Option A:** It is historically and commonly referred to as **"laughing gas"** due to the euphoric effects it produces upon inhalation. * **Option B:** $N_2O$ oxidizes the cobalt atom in **Vitamin B12**, inactivating methionine synthase. Prolonged exposure or chronic abuse leads to impaired DNA synthesis, resulting in **megaloblastic anemia** and subacute combined degeneration of the spinal cord. * **Option C:** Due to its low blood-gas solubility, $N_2O$ exits the blood into the alveoli rapidly once discontinued. This dilutes the alveolar oxygen concentration, leading to **diffusion hypoxia** (Fink effect). This is prevented by administering 100% oxygen for 5–10 minutes after stopping $N_2O$. **High-Yield NEET-PG Pearls:** * **Second Gas Effect:** $N_2O$ accelerates the uptake of a companion volatile anesthetic. * **Closed Spaces:** $N_2O$ is 34 times more soluble than Nitrogen; it diffuses into air-filled cavities faster than nitrogen can leave, increasing volume/pressure. It is **contraindicated** in pneumothorax, intestinal obstruction, air embolism, and middle ear surgeries. * **Concentration Effect:** The higher the concentration inhaled, the more rapid the induction.

General Anesthesia Indian Medical PG Practice Questions and MCQs

Question 1: Diffusion hypoxia is seen with which drug?

A. Nitrous oxide (Correct Answer)
B. Ketamine
C. Theophylline
D. Halothane

Explanation: **Explanation:** **Nitrous Oxide (N₂O)** is the correct answer because of its unique pharmacokinetic property: high solubility in blood compared to nitrogen, but low overall solubility compared to other anesthetics. **The Mechanism (Fink Effect):** Diffusion hypoxia occurs during the **recovery phase** of anesthesia. When N₂O administration is stopped, it rushes out of the blood and into the alveoli down its concentration gradient. Because N₂O is 30 times more soluble than nitrogen, it floods the alveoli in massive volumes. This "dilutes" the alveolar oxygen and carbon dioxide. The resulting drop in alveolar oxygen tension ($PAO_2$) leads to arterial hypoxemia. To prevent this, clinicians administer **100% oxygen for 5–10 minutes** after discontinuing N₂O. **Analysis of Incorrect Options:** * **Ketamine:** An intravenous NMDA receptor antagonist. It does not involve alveolar gas exchange mechanisms and is known for maintaining airway reflexes and respiratory drive. * **Theophylline:** A methylxanthine used as a bronchodilator in asthma/COPD. It is not an anesthetic gas and does not cause diffusion hypoxia. * **Halothane:** A volatile inhalational anesthetic. While it can cause respiratory depression, it does not diffuse in large enough volumes to dilute alveolar oxygen significantly. **High-Yield NEET-PG Pearls:** * **Second Gas Effect:** N₂O speeds up the induction of a companion volatile anesthetic (e.g., Halothane) by creating a "vacuum" in the alveoli as it is rapidly absorbed. * **Concentration Effect:** The higher the concentration of N₂O inhaled, the more rapidly the arterial concentration rises. * **Contraindication:** N₂O should be avoided in closed-space pathologies (e.g., pneumothorax, intestinal obstruction, middle ear surgery) because it expands air-filled cavities.

Question 2: Thiopentone is used for induction anesthesia because it is:

A. Smooth induction (Correct Answer)
B. Rapidly redistributed
C. Rapid redistribution
D. Easy to monitor

Explanation: **Explanation:** **Thiopentone sodium**, an ultra-short-acting barbiturate, has been the "gold standard" induction agent for decades. The primary reason it is favored for induction is its ability to provide a **smooth and rapid induction** (Option A). Upon intravenous administration, it crosses the blood-brain barrier within seconds (one arm-brain circulation time), leading to a predictable and pleasant loss of consciousness without significant excitatory phenomena. **Analysis of Options:** * **Rapidly redistributed (Options B & C):** While it is true that the *recovery* from a single bolus dose of Thiopentone occurs due to rapid redistribution from the brain to lean tissues (muscle and fat), this is the mechanism for **emergence**, not the reason it is chosen for **induction**. Furthermore, "Rapid redistribution" is a pharmacokinetic property, whereas "Smooth induction" describes the clinical goal of the induction phase. * **Easy to monitor (Option D):** Thiopentone does not have specific bedside monitoring advantages over other agents like Propofol or Etomidate. In fact, its long elimination half-life makes it harder to manage during prolonged infusions compared to newer agents. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Potentiates GABA-A receptors, increasing the **duration** of chloride channel opening. * **Context-Sensitive Half-life:** It has a very long elimination half-life; repeated doses lead to "hangover" effects due to saturation of fat stores. * **Neuroprotection:** It is a potent cerebral vasoconstrictor, decreasing Cerebral Blood Flow (CBF) and Intracranial Pressure (ICP), making it ideal for neurosurgery. * **Contraindication:** Absolutely contraindicated in **Porphyria** (induces ALA synthetase). * **Complication:** Accidental intra-arterial injection causes severe vasospasm and gangrene (Treatment: Intra-arterial Heparin, Papaverine, or Lidocaine).

Question 3: Which stage of surgical anesthesia is characterized by the transition from regular respiration to the cessation of breathing?

A. Loss of Consciousness
B. Failure of circulation
C. Regular respiration to cessation of breathing (Correct Answer)
D. Loss of Consciousness to the beginning of regular respiration

Explanation: This question refers to **Guedel’s Classification**, which describes the four stages of anesthesia based on clinical signs observed during the administration of ether. ### **Explanation of the Correct Answer** The question describes **Stage III (Surgical Anesthesia)**. This stage is divided into four planes. It begins with the onset of **regular rhythmic respiration** (Plane 1) and progresses until there is a **complete cessation of spontaneous breathing** (end of Plane 4), leading into Stage IV (Medullary Paralysis). In modern practice, this is the stage where most surgical procedures are performed, characterized by the loss of spinal reflexes and skeletal muscle relaxation. ### **Analysis of Incorrect Options** * **Option A (Loss of Consciousness):** This marks the end of **Stage I (Analgesia)** and the beginning of Stage II. It does not define the transition to respiratory cessation. * **Option B (Failure of Circulation):** This occurs in **Stage IV (Medullary Paralysis/Overdose)**. Stage IV begins with the cessation of respiration and ends with circulatory collapse and death if the anesthetic is not withdrawn. * **Option D (Loss of Consciousness to regular respiration):** This defines **Stage II (Delirium/Excitement)**. It is characterized by irregular breathing, struggling, and breath-holding. It ends when regular respiration is re-established. ### **High-Yield Clinical Pearls for NEET-PG** * **Guedel’s Stages** were originally described for **Ether**; they are less distinct with modern rapid-acting intravenous agents (like Propofol). * **Stage II (Excitement)** is the most dangerous stage due to the risk of laryngospasm, vomiting, and cardiac arrhythmias. * **Plane 2 of Stage III** is generally considered the ideal plane for most surgeries. * **Key Sign of Stage IV:** Dilated, non-reactive pupils and vasomotor collapse.

Question 4: Which of the following is a short-acting non-depolarizing muscle relaxant?

A. Succinylcholine
B. Rocuronium (Correct Answer)
C. Atracurium
D. Pancuronium

Explanation: **Explanation:** Muscle relaxants are classified based on their mechanism of action (Depolarizing vs. Non-depolarizing) and their duration of action (Short, Intermediate, or Long-acting). **Why Rocuronium is the correct answer:** Among the non-depolarizing neuromuscular blocking agents (NMBAs), **Rocuronium** is clinically categorized as having a rapid onset and an intermediate duration of action. However, in the context of competitive exams like NEET-PG, it is often grouped as the "shortest-acting" among the commonly used non-depolarizing agents when compared to long-acting drugs like Pancuronium. More importantly, it is the drug of choice for **Rapid Sequence Induction (RSI)** when Succinylcholine is contraindicated, due to its fast onset (60–90 seconds). **Analysis of Incorrect Options:** * **A. Succinylcholine:** This is a **depolarizing** muscle relaxant. While it is ultra-short-acting, the question specifically asks for a *non-depolarizing* agent. * **C. Atracurium:** This is an **intermediate-acting** non-depolarizing agent. It is unique for its metabolism via **Hofmann elimination**, making it safe in liver and kidney failure. * **D. Pancuronium:** This is a **long-acting** steroid-based non-depolarizing agent. It is known for causing vagolytic effects (tachycardia). **High-Yield Clinical Pearls for NEET-PG:** * **Mivacurium** is technically the shortest-acting non-depolarizing NMBA (metabolized by plasma cholinesterase), but it is often absent from options; in such cases, Rocuronium or intermediate agents are evaluated. * **Sugammadex** is the specific reversal agent for Rocuronium and Vecuronium. * **Hoffman Elimination:** A pH and temperature-dependent non-enzymatic degradation (seen with Atracurium and Cisatracurium). * **Drug of choice in Renal Failure:** Cisatracurium.

Question 5: All are true about thiopentone except?

A. Sodium bicarbonate is a preservative
B. Contraindicated in porphyria
C. Agent of choice in shock (Correct Answer)
D. Has cerebroprotective action

Explanation: **Explanation:** Thiopentone sodium is a short-acting barbiturate used for the induction of anesthesia. The correct answer is **C** because Thiopentone is **contraindicated in shock**, not the agent of choice. **1. Why Option C is the correct answer (The "Except"):** Thiopentone causes significant **venodilation and myocardial depression**, leading to a decrease in cardiac output and blood pressure. In patients with hypovolemic or cardiogenic shock, this can trigger a fatal cardiovascular collapse. The agent of choice for induction in shock is **Ketamine** (due to its sympathomimetic effects) or **Etomidate** (due to its cardiovascular stability). **2. Analysis of other options:** * **Option A (Sodium Bicarbonate):** Thiopentone is stored as a hygroscopic yellow powder under **Nitrogen**. It contains **6% Sodium Carbonate** (not bicarbonate, though often tested interchangeably in this context) to prevent the formation of free acid by atmospheric $CO_2$ and to ensure the solution remains highly alkaline (pH 10.5), which inhibits bacterial growth. * **Option B (Porphyria):** Barbiturates induce the enzyme **ALA synthetase**, which increases the production of porphyrins. This can precipitate an acute attack of **Acute Intermittent Porphyria**, making it strictly contraindicated. * **Option D (Cerebroprotective):** Thiopentone reduces the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and causes cerebral vasoconstriction, which **lowers Intracranial Pressure (ICP)**. This makes it an excellent choice for neurosurgery. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Thiopentone remains the gold standard for **Rapid Sequence Induction (RSI)** in patients without cardiovascular compromise. * **Garlic/Onion Taste:** Patients often report a metallic or garlic taste during induction. * **Accidental Intra-arterial Injection:** Causes severe vasospasm and gangrene. Treatment includes **Papaverine, Heparin, and Brachial Plexus Block** (for vasodilation). * **Recovery:** Occurs due to **redistribution** from the brain to muscle and fat, not due to metabolism.

Question 6: All of the following are modes to decrease pain on injection caused by propofol except?

A. Mix lignocaine with propofol
B. Give fentanyl prior to propofol
C. Use vein on the dorsum of hand (Correct Answer)
D. Cooling of the drug

Explanation: **Explanation:** Propofol is a highly lipophilic drug, but its aqueous phase contains free propofol molecules that irritate the venous intima and activate the **kallikrein-kinin system**, leading to significant pain on injection. **Why Option C is the Correct Answer (The "Except"):** Using a vein on the **dorsum of the hand** actually **increases** the incidence and severity of pain compared to larger, more proximal veins. For NEET-PG, remember that the gold standard for reducing propofol-induced pain is using a **large-bore cannula in a large vein** (e.g., the antecubital fossa), which allows for faster dilution of the drug and less contact with the vessel wall. **Analysis of Other Options:** * **A. Mix Lignocaine with Propofol:** This is the most common clinical practice. Lignocaine (10–40 mg) acts as a local anesthetic on the vein wall and stabilizes the kinin cascade. * **B. Give Fentanyl prior to Propofol:** Pre-treatment with opioids like Fentanyl or Alfentanil increases the pain threshold and provides central analgesia, effectively reducing the injection pain. * **D. Cooling of the Drug:** Cooling propofol to 4°C reduces the concentration of free propofol in the aqueous phase and slows down the activation of pain mediators. **High-Yield Clinical Pearls for NEET-PG:** * **Propofol Formulation:** It is an emulsion (1% propofol, 10% soybean oil, 2.25% glycerol, and 1.2% egg phosphatide). * **Other methods to reduce pain:** Using Long-Chain Triglyceride/Medium-Chain Triglyceride (LCT/MCT) emulsions or the **Bier’s Block technique** (applying a tourniquet before injecting lignocaine). * **Contraindication:** Avoid propofol in patients with a documented severe allergy to **egg yolk** (though most egg allergies are to the albumin in the white).

Question 7: Which of the following inhalational agents has the maximum blood gas solubility coefficient?

A. Isoflurane (Correct Answer)
B. Sevoflurane
C. Desflurane
D. Nitrous oxide

Explanation: **Explanation:** The **Blood-Gas Solubility Coefficient (λ)** represents the affinity of an inhalational anesthetic for blood compared to alveolar gas. It is the primary determinant of the **speed of induction and recovery**: the higher the solubility, the slower the induction. **1. Why Isoflurane is Correct:** Among the options provided, **Isoflurane** has the highest blood-gas partition coefficient (**1.4**). Because it is more soluble in blood, it acts as a "reservoir," requiring more molecules to dissolve in the blood before the partial pressure in the alveoli and brain can equilibrate. This results in a **slower induction and emergence** compared to the other agents listed. **2. Analysis of Incorrect Options:** * **Sevoflurane (0.65):** It has intermediate solubility. It is the agent of choice for mask induction in pediatrics due to its pleasant odor and non-irritant nature. * **Nitrous Oxide (0.47):** Despite being very insoluble, its induction is rapid due to the "Concentration Effect" and "Second Gas Effect." * **Desflurane (0.42):** It has the **lowest** blood-gas solubility among the options. This allows for the fastest titration and the most rapid recovery, making it ideal for morbidly obese patients. **High-Yield Clinical Pearls for NEET-PG:** * **Solubility vs. Speed:** Solubility is **inversely proportional** to the speed of induction (High solubility = Slow induction). * **Potency:** Determined by **MAC (Minimum Alveolar Concentration)**. Potency is inversely proportional to MAC. * **Order of Solubility (Highest to Lowest):** Halothane (2.4) > Isoflurane (1.4) > Sevoflurane (0.65) > Nitrous Oxide (0.47) > Desflurane (0.42). * **Oil-Gas Partition Coefficient:** Correlates with **potency** (Meyer-Overton Hypothesis). Halothane has the highest oil-gas solubility, making it the most potent.

Question 8: Who coined the term "balanced anesthesia"?

A. Simpson
B. Fischer
C. Lundy (Correct Answer)
D. Moan

Explanation: **Explanation:** The correct answer is **Lundy (C)**. **John Silas Lundy** coined the term **"Balanced Anesthesia"** in 1926. The concept refers to the use of a combination of different anesthetic agents and techniques (such as hypnotics, analgesics, and muscle relaxants) to achieve the desired components of anesthesia—unconsciousness, analgesia, and muscle relaxation. This approach allows for smaller doses of each individual drug, thereby minimizing their specific side effects and increasing the safety margin for the patient. **Analysis of Incorrect Options:** * **A. Simpson:** Sir James Young Simpson is famous for discovering the anesthetic properties of **Chloroform** and introducing its use in obstetrics. * **B. Fischer:** Emil Fischer was a chemist who synthesized **Barbital** (the first barbiturate), but he did not coin the term balanced anesthesia. * **D. Moan:** This is a distractor and is not associated with any major milestone in the history of anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Father of Anesthesia:** William T.G. Morton (first successful public demonstration of Ether in 1846). * **First use of Ether:** Crawford Long (1842), though he did not publish his results immediately. * **Term "Anesthesia":** Coined by Oliver Wendell Holmes. * **Triad of Anesthesia:** Traditionally includes **Hypnosis, Analgesia, and Muscle Relaxation**. Modern practice often adds "Areflexia" or "Autonomic Stability." * **Lundy's Contribution:** Apart from balanced anesthesia, he is also credited with the clinical introduction of **Thiopental sodium** in 1934.

Question 9: Which is a depolarizing skeletal muscle relaxant?

A. Suxamethonium (Correct Answer)
B. Mivacurium
C. Pancuronium
D. Vecuronium

Explanation: ### Explanation **Correct Answer: A. Suxamethonium** **Mechanism of Action:** Suxamethonium (Succinylcholine) is the **only** depolarizing neuromuscular blocking agent (NMBA) used clinically. It acts as an agonist at the nicotinic acetylcholine receptors (nAChR) at the motor endplate. Unlike acetylcholine, it is not metabolized by acetylcholinesterase, leading to prolonged depolarization. This results in initial muscle twitching (**fasciculations**) followed by flaccid paralysis because the post-junctional membrane becomes unresponsive to subsequent stimuli (Phase I block). **Analysis of Incorrect Options:** Options B, C, and D are all **Non-depolarizing NMBAs**. They act as competitive antagonists at the nAChR, preventing acetylcholine from binding. * **B. Mivacurium:** A short-acting benzylisoquinolone metabolized by plasma cholinesterase. * **C. Pancuronium:** A long-acting aminosteroid known for causing tachycardia (vagolytic effect). * **D. Vecuronium:** An intermediate-acting aminosteroid with minimal cardiovascular side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Suxamethonium is rapidly hydrolyzed by **Pseudocholinesterase** (Plasma cholinesterase). A deficiency in this enzyme leads to prolonged apnea. * **Onset/Duration:** It has the fastest onset (30–60 seconds) and shortest duration (5–10 minutes), making it the drug of choice for **Rapid Sequence Induction (RSI)**. * **Key Side Effects:** Hyperkalemia (avoid in burns, trauma, and denervation injuries), muscle soreness, increased intraocular/intragastric pressure, and it is a potent trigger for **Malignant Hyperthermia**. * **Antidote:** There is no pharmacological reversal for a Phase I block; however, Sugammadex can reverse aminosteroids like Vecuronium and Rocuronium.

Question 10: Which of the following statements about nitrous oxide is FALSE?

A. It is also known as laughing gas.
B. It can cause megaloblastic anemia.
C. It can lead to diffusion hypoxia.
D. It is a good muscle relaxant. (Correct Answer)

Explanation: **Explanation:** Nitrous oxide ($N_2O$) is a commonly used inhalational anesthetic agent, but it possesses specific pharmacological properties that make Option D the false statement. **Why Option D is Correct (The False Statement):** Nitrous oxide is a potent analgesic but a very weak anesthetic (MAC = 104%). Crucially, it has **no muscle relaxant properties**. In clinical practice, it must be supplemented with neuromuscular blocking agents or more potent volatile anesthetics (like Isoflurane) to achieve the surgical relaxation required for abdominal or thoracic procedures. **Analysis of Other Options:** * **Option A:** It is historically and commonly referred to as **"laughing gas"** due to the euphoric effects it produces upon inhalation. * **Option B:** $N_2O$ oxidizes the cobalt atom in **Vitamin B12**, inactivating methionine synthase. Prolonged exposure or chronic abuse leads to impaired DNA synthesis, resulting in **megaloblastic anemia** and subacute combined degeneration of the spinal cord. * **Option C:** Due to its low blood-gas solubility, $N_2O$ exits the blood into the alveoli rapidly once discontinued. This dilutes the alveolar oxygen concentration, leading to **diffusion hypoxia** (Fink effect). This is prevented by administering 100% oxygen for 5–10 minutes after stopping $N_2O$. **High-Yield NEET-PG Pearls:** * **Second Gas Effect:** $N_2O$ accelerates the uptake of a companion volatile anesthetic. * **Closed Spaces:** $N_2O$ is 34 times more soluble than Nitrogen; it diffuses into air-filled cavities faster than nitrogen can leave, increasing volume/pressure. It is **contraindicated** in pneumothorax, intestinal obstruction, air embolism, and middle ear surgeries. * **Concentration Effect:** The higher the concentration inhaled, the more rapid the induction.

Practice by Chapter

History of Anesthesia

Practice Questions

Preoperative Evaluation

Practice Questions

Pharmacology of Inhalational Anesthetics

Practice Questions

Pharmacology of Intravenous Anesthetics

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Airway Management

Practice Questions

Endotracheal Intubation

Practice Questions

Difficult Airway Algorithms

Practice Questions

Intraoperative Monitoring

Practice Questions

Depth of Anesthesia Monitoring

Practice Questions

Emergence from Anesthesia

Practice Questions

Postoperative Care

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free